Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Stroke 36:287-291, Audebert, H.J., et al, 2005
Aggressive Mechanical Clot Disruption
Stroke 36:292-296, Noser, E.A., et al, 2005
Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005
Combined IV and intra-arterial thrombolysis for acute ischemic stroke
Neurol 64:386-388, Flaherty, M.L., et al, 2005
Do the Brain Attack Coalition's Criteria for Stroke Centers Improve Care for Ischemic Stroke?
Neurol 64:422-427, Douglas, V.C., et al, 2005
A Trial of Metoclopramide vs Sumatriptan for the Emergency Department Treatment of Migraines
Neurol 64:463-468, Friedman, B.W., et al, 2005
Intraocular Haemorrhage after Thrombolysis
Lancet 365:330, Kaba, R.A., et al, 2005
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005
Prioritizing interventions to Improve Rates of Thrombolysis for Ischemic Stroke
Neurol 64:654-659, California Acute Stroke Pilot Registry (CASPR) Inv, 2005
Reasons for Exclusion From Thrombolytic Therapy Following Acute Ischemic Stroke
Neurol 64:719-720, Cocho,D., et al, 2005
Spinal Cord Transient Ischemic Attacks: A Possible Role for Abciximab
Neurol 64: 761-762, Hussain, M.S., et al, 2005
Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-analysis
BMJ 330:342-345, Bath, P.M.W. & Gray, L.J., 2005
Efficacy of Aspirin Plus Extended-Release Dipyridamole in Preventing Recurrent Stroke in High-Risk Populations
Arch Neurol 62:403-408, Sacco, R.L., et al, 2005
Acute Tetrodotoxin-Induced Neurotoxicity After Ingestion of Puffer Fish
Ann Neurol 57:339-348, 309, Kiernan, M.C., et al, 2005
Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
NEJM 352:987-996, 1036, Stupp,R., et al, 2005
MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma
NEJM 352:997-1003, 1036, Hegi,M.E., et al, 2005
Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone
NEJM 352:10 978-986, 1036, Rutkowski,S., et al, 2005
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005
Sonothrombolysis in Acute Ischemic Stroke for Patients Ineligible for rt-PA
Neurol 64:1052-1054, Eggers,J., et al, 2005
Prospective Reliability of the Stroke Doc Wireless/Site Independent Telemedicine System
Neurol 64:1058-1060, Meyer,B.C., et al, 2005
Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005
Central Nervous System Lymphoma Associated with Mycophenolate Mofetil in Lupus Nephritis
Lupus 14:910-913, Dasgupta,N.,et al, 2005
Treatment and Prevention of Primary Intracerebral Hemorrhage
Semin Neurol 25:445-452, Towfighi,A.,et al, 2005
Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005
Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005
Posterior Cerebral Artery Stroke
e medicine, Hill,M.D., 2005
A Case of Reversible Postpartum Cytotoxic Edema in Preeclampsia
JNeuroSci 221:83-87, Na,S.-J.,et al, 2004
Fibrinogen-Depleting Agents for Acute Ischemic Stroke
Stroke 36:173-174, Liu,M.,et al, 2004
Early MRI Findings in Patients Receiving Tissue Plasminogen Activator Predict Outcome: Insights into the Pathophysiology of Acute Stroke in the Thrombolysis Era
Ann Neurol 55:105-112, Chalela,J.A.,et al, 2004
Antiplatelet Drug Discontinuation is a Risk Factor for Ischemic Stroke
Neurol 62:1187-1189, Sibon,I. &Orgogozo,J-M., 2004
Oral Simvastin Treatment in Relapsing-Remitting Multiple Sclerosis
Lancet 363:1607-1608,1570, Vollmer,T.,et al, 2004
Intravenous r-TPA in Vertebrobasilar Acute Infarcts
Neurol 62:1854-1856, Montavont,A.,et al, 2004
Vasculitic Mononeuritis Multiplex Induced by Valcyclovir
Neurol 62:1906-1907, Pary,L.F.,et al, 2004
Recurrent Meningitis of Unknown Aetiology
Lancet 363:1772, Ellerin,T.B.,et al, 2004
Therapy for Nerve Agent Poisoning
Arch Neurol 61:649-652, Newmark,J., 2004
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Treatment of Refractory Neurosarcoidosis with Cladribine
NEJM 350:1798-1799, Tikoo,R.K.,et al, 2004
Clinicopath Conf., Progessive Multifocal Leukoencephalopathy
NEJM 350:1884-1893, Case 14-2004, 2004
Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke 35:1117-1123, Marti-Fabregas,J.,et al, 2004
Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004
Mitoxantrone for Multiple Sclerosis in Clinical Practice
Neurol 63(Suppl 6):S25-S27, Rizvi,S.A.,et al, 2004
Parenteral Metoclopramide for Acute Migraine: Meta-Analysis of Randomised Controlled Trials
BMJ 329:1369-1372, Colman,I.,et al, 2004
Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004
Fatal Inflammatory AIDS-Associated PML with High CD4 Counts on HAART: A New Clinical Entity?
Neurol 63:2452-2453, Di Giambenedetto,S.,et al, 2004
Intra-Arterial Thrombolysis of Complete Deep Cerebral Venous Thrombosis
Neurol 63:2444-2445, Liebetrau,M.,et al, 2004
Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004
Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004
Steroids Have No Role in Stroke Therapy
Stroke 35:229-231, Poungvarin,N.,et al, 2004
Steroids May Have a Role in Stroke Therapy
Stroke 35:228-229,230, Norris,J.W., 2004